7 results on '"Lei, Siyuan"'
Search Results
2. Review on post-combustion CO2 capture by amine blended solvents and aqueous ammonia
- Author
-
Du, Jiaxing, Yang, Wu, Xu, Linlin, Bei, Lei, Lei, Siyuan, Li, Wei, Liu, Haitao, Wang, Ben, and Sun, Lushi
- Published
- 2024
- Full Text
- View/download PDF
3. Low-Profile Multibeam Beam-Scanning Antenna for Vehicular Radar Systems
- Author
-
Lei, Siyuan, primary, Wei, Gao, additional, Han, Kangkang, additional, Qiu, Tiancheng, additional, and Wang, Min, additional
- Published
- 2024
- Full Text
- View/download PDF
4. 2-D Multibeam Leaky-Wave Antenna Based on Modified Luneburg Lens
- Author
-
Lei, Siyuan, Wei, Gao, Han, Kangkang, Qiu, Tiancheng, and Wang, Min
- Abstract
In this letter, a multibeam leaky-wave antenna (LWA) based on a modified Luneburg lens (LL) beamforming network is proposed. The antenna performs a simple structure and low profile with 2-D beam scanning. First, the modified LL serves as a beamforming network since its variation range ratio of refractive index can be determined by the relative permittivity of the substrate. This can be simply achieved using a printed circuit board technique rather than the square root of two of conventional LL. Then, the relationship between the input port angle and the multibeam angle is analyzed using the geometric-optical method. Finally, a high-scanning-rate LWA array based on spoof surface plasmon polaritons is designed, and its open-stopband is effectively suppressed. A prototype is simulated and fabricated. The measured results show that the proposed antenna has a multibeam range of −42° to 40° in the E-plane and a beam scanning range of −53° to 44° in the H-plane within 8–10.5 GHz, which agrees well with the calculation and simulation.
- Published
- 2024
- Full Text
- View/download PDF
5. Dual Circularly Polarized and Linearly Sweeping Leaky-Wave Antenna
- Author
-
Lei, Siyuan, Wei, Gao, Han, Kangkang, Qiu, Tiancheng, and Wang, Min
- Abstract
In this letter, a dual circularly polarized periodic leaky-wave antenna based on spoof surface plasmon polaritons (SSPPs) with linearly sweeping beams is proposed. The antenna can simultaneously radiate left-handed circular polarization (LHCP) and right-handed circular polarization (RHCP) beams. Single-arm Archimedean spirals serve as radiators and are designed. Based on linearity analysis and curve fitting, SSPPs structure with potentially linear scanning ability are selected. Finally, the axial ratio (AR) and S-parameter for the proposed SSPPs antenna with spiral radiators are optimized around the broadside frequency using longitudinally asymmetric analysis. A prototype is fabricated and measured results show that the proposed antenna achieves a relative 3 dB AR bandwidth of 31.6% (8–11 GHz) with the same LHCP and RHCP scanning range of 65° and linearly sweeping ability.
- Published
- 2024
- Full Text
- View/download PDF
6. Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer in Men With Hip Prostheses: A Cautionary Note.
- Author
-
Shah S, Saravanakumar S, Conroy D, Sowmiyanarayanan S, Singh R, Pepin A, Rashid H, Danner MT, Krishnan P, Lei S, Rashid A, Suy S, Kataria S, Aghdam N, and Collins S
- Abstract
Purpose: Stereotactic body radiation therapy (SBRT) has been established as a safe and effective treatment for prostate cancer. SBRT requires high accuracy to reduce treatment margins. Metal hip prostheses create artifacts that distort pelvic imaging and potentially decrease the accuracy of target/organ at risk (OAR) identification and radiation dose calculations. Data on the safety and efficacy of SBRT after hip replacement is limited. This single-institution study sought to evaluate the safety and local control following SBRT for prostate cancer in men with hip replacements., Methods: 23 patients treated with localized prostate cancer and a history of pre-treatment hip replacement, treated with SBRT from 2007 to 2017 at MedStar Georgetown University Hospital were included in this retrospective analysis. Treatment was administered with the CyberKnife
® (Accuray Incorporated, Sunnyvale, CA) at doses of 35 Gy or 36.25 Gy in 5 fractions. The targets and OARs were identified and contoured by a single experienced Radiation Oncologist (SPC). The adequacy of the CT and T2W MRI images for treatment planning was assessed with a three-point scale (good, adequate, or suboptimal). During treatment planning, care was taken to avoid treatment beams that directly traversed the hip prosthesis. Toxicities were recorded and scored using the Common Terminology Criteria for Adverse Events version 4.0 (CTCAE v.4.0). Local recurrence was confirmed by magnetic resonance imaging and/or prostate biopsy., Results: The median follow-up was seven years. The patients were elderly (median age = 71 years) with a high rate of comorbidities (Charlson Comorbidity Index > 2 in 25%). Four patients had bilateral hip replacements. The majority of patients were low to intermediate risk per the D'Amico classification. Around 13% received upfront ADT. In total, 13 patients were treated with 35 Gy, and 10 were treated with 36.25 Gy. The rates of late > Grade 3 GU toxicity and > Grade 2 GI toxicity were 8.6% and 4.3%, respectively. There were no Grade 4 or 5 toxicities. Six patients (26%) developed a local recurrence at a median time of 7.5 years. Of these six patients, four had unilateral hip replacements and two had bilateral. Three underwent salvage cryotherapy and three received salvage ADT., Conclusions: In the general population, high-grade toxicities and local recurrences are uncommon following prostate SBRT. However, in this cohort of patients with prior hip replacements, prostate SBRT had higher than expected rates of late toxicity and local recurrence. In the opinion of the authors, such patients should be counseled regarding an elevated risk of late toxicity and local recurrence with prostate SBRT. With its ultrasound guidance, brachytherapy would have the advantage of circumventing the need for MRI/CT-based imaging and thus may represent a preferable radiation alternative in this patient population. If these patients are treated with SBRT, they should be monitored closely for local recurrence so early salvage can be performed. We hope that recent advances in metal artifact reduction techniques and dose-calculation algorithms will improve future outcomes., Competing Interests: Human subjects: Consent was obtained or waived by all participants in this study. Georgetown University Institutional Review Board issued approval 2009-510. Approval from the MedStar Georgetown University Institutional Review Board was obtained for retrospective review of prospectively collected data in our institutional database (IRB#: 2009-510). Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: This work was supported by the James and Theodore Pedas Family Foundation. Additionally, SP Collins serves as a clinical consultant to Accuray Inc. The Department of Radiation Medicine at Medstar Georgetown University Hospital recieves a grant from Accuray to support a research coordinator. The other authors declare they have no competing interests. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work., (Copyright © 2024, Shah et al.)- Published
- 2024
- Full Text
- View/download PDF
7. Prognostic utility of biopsy-based PTEN and ERG status on biochemical progression and overall survival after SBRT for localized prostate cancer.
- Author
-
Repka MC, Sholklapper T, Zwart AL, Danner M, Ayoob M, Yung T, Lei S, Collins BT, Kumar D, Suy S, Hankins RA, Kishan AU, and Collins SP
- Abstract
Introduction/background: Phosphatase and tensin homolog (PTEN) genomic deletions and transmembrane protease, serine 2/v-ets avian erthyroblastosis virus E26 oncogene homolog (ERG) rearrangements are two of the most common genetic abnormalities associated with prostate cancer. Prior studies have demonstrated these alterations portend worse clinical outcomes. Our objective is to evaluate the impact of biopsy-determined PTEN losses and TMPRSS2-ERG fusion on biochemical progression-free survival (bPFS) and overall survival (OS) in patients who receive SBRT for localized prostate cancer., Methods/materials: Patients received SBRT for localized prostate cancer on a prospective quality-of-life (QoL) and cancer outcomes study. For each patient, the single biopsy core with the highest grade/volume of cancer was evaluated for PTEN and ERG abnormalities. Differences in baseline patient and disease characteristics between groups were analyzed using ANOVA for age and χ
2 for categorical groupings. bPFS and OS were calculated using the Kaplan Meier (KM) method with Log-Rank test comparison between groups. Predictors of bPFS and OS were identified using the Cox proportional hazards method. For all analyses, p < 0.05 was considered statistically significant., Results: Ninety-nine consecutive patients were included in the analysis with a median follow-up of 72 months. A statistically significant improvement in bPFS ( p = 0.018) was observed for wild type ERG patients with an estimated 5-year bPFS of 94.1% vs. 72.4%. Regarding PTEN mutational status, significant improvements in were observed in both bPFS (p = 0.006) and OS (p < 0.001), with estimated 5-year bPFS rates of 91.0% vs. 67.9% and 5-year OS rates of 96.4% vs. 79.4%. When including both ERG and PTEN mutational status in the analysis, there were statistically significant differences in both bPFS (p = 0.011) and OS (p < 0.001). The estimated 5-year bPFS rates were 100%, 76.6%, 72.9%, and 63.8% for patients with ERG+/PTEN+, ERG-/PTEN+, ERG+/PTEN-, and ERG-/PTEN- phenotypes respectively. The estimated 5-year OS rates were 93.9%, 100%, 80.0%, and 78.7% for patients with ERG+/PTEN+, ERG-/PTEN+, ERG+/PTEN-, and ERG-/PTEN- phenotypes respectively., Conclusion: ERG rearrangements and PTEN deletions detected on biopsy samples are associated with poorer oncologic outcomes in prostate cancer patients treated with SBRT and merit further study in a dedicated prospective trial., Competing Interests: SC serves as a consultant for Accuray Sunnyvale, CA and Boston Scientific Marlborough, MA. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer CZ declared a past co-authorship with the authors AK and SC to the handling editor. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision., (Copyright © 2024 Repka, Sholklapper, Zwart, Danner, Ayoob, Yung, Lei, Collins, Kumar, Suy, Hankins, Kishan and Collins.)- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.